ARTICLE | Clinical News
Subazole: Pivotal trial data
October 13, 2008 7:00 AM UTC
A pivotal study showed that SUBA-Itraconazole produced comparable pharmacokinetics to Sporanox itraconazole from Johnson & Johnson (NYSE:JNJ, New Brunswick, N.J.). Halcygen has exclusive worldwide ri...